FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:516-518 August 24, 1995 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Granulocyte colony-stimulating factor (G-CSF) is one of the latest products of molecular biology to permeate clinical practice. The results with this hematopoietic growth factor have been promising, and in one disease, congenital severe neutropenia, they have been exceptionally interesting. But questions have been raised about the safety of G-CSF in this rare disorder. To understand the clinical effects of G-CSF and the concern about its safety, it is important to know that the growth factor has multiple effects on cells of the granulocytic lineage. It not only stimulates the proliferation and differentiation of myeloid precursors but also enhances the functional . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Anderlini, P., Champlin, R. E. (2008). Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges. Blood 111: 1767-1772 [Abstract] [Full Text]  
• Wolfler, A., Erkeland, S. J., Bodner, C., Valkhof, M., Renner, W., Leitner, C., Olipitz, W., Pfeilstocker, M., Tinchon, C., Emberger, W., Linkesch, W., Touw, I. P., Sill, H. (2005). A functional single-nucleotide polymorphism of the G-CSF receptor gene predisposes individuals to high-risk myelodysplastic syndrome. Blood 105: 3731-3736 [Abstract] [Full Text]  
• Weinberg, K. (2004). Can increased cytokine receptor signaling cause leukemia?. Blood 103: 1976-1977 [Full Text]  
• White, S. M., Alarcon, M. H., Tweardy, D. J. (2000). Inhibition of granulocyte colony-stimulating factor-mediated myeloid maturation by low level expression of the differentiation-defective class IV granulocyte colony-stimulating factor receptor isoform. Blood 95: 3335-3340 [Abstract] [Full Text]  
• Sreenan, C., Osiovich, H. (1999). Myeloid Colony-Stimulating Factors: Use in the Newborn. Arch Pediatr Adolesc Med 153: 984-988 [Abstract] [Full Text]  
• Carr, R., Modi, N., Doré, C. J., El-Rifai, R., Lindo, D. (1999). A Randomized, Controlled Trial of Prophylactic Granulocyte-Macrophage Colony-Stimulating Factor in Human Newborns Less Than 32 Weeks Gestation. Pediatrics 103: 796-802 [Abstract] [Full Text]  
• Carr, R., Modi, N. (1997). Haemopoietic colony stimulating factors for preterm neonates. Arch. Dis. Child. Fetal Neonatal Ed. 76: 128F-133 [Full Text]